Ellence 2 mg/mL

Ellence 2 mg/mL is an injectable solution containing epirubicin hydrochloride, used for specific medical treatments. This single-dose vial is designed for intravenous administration and is manufactured by Pharmacia & Upjohn Company LLC.

Ellence 2 mg/mL is primarily used in the treatment of certain types of cancer. It works by interfering with the growth of cancer cells, making it a key component in chemotherapy regimens. Patients often wonder, 'What is Ellence used for?' and the answer lies in its role as an antineoplastic agent, targeting the proliferation of malignant cells.

Common effects of Ellence 2 mg/mL may include nausea, vomiting, and fatigue. Some patients also experience hair loss and changes in blood cell counts. These effects can vary widely depending on the individual and the specific treatment plan.

Ellence 2 mg/mL should be handled with care, as it is a potent medication. It is important to follow the instructions provided by healthcare professionals regarding administration and disposal. Pregnant women and individuals with certain medical conditions should exercise caution and consult their healthcare provider before use.

Ellence 2 mg/mL may interact with other medications, including those that affect the liver or bone marrow. It is advisable to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and certain supplements may also impact the effectiveness and safety of Ellence.